Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
R.BarbieriM.FavaI.DesiderioM.CoppolaC.MarfellaR.et al (2016)
describe compelling preclinical synergy of APR-246 in combination with azacitidine in TP53 mutated MDS and AML and, more importantly, identify a novel molecular mechanism underlying the observed synergy
Purpose-built for physicians GLP-1 receptor agonist tied to similar thyroid cancer risk as DPP-IV, SGLT2 inhibitors Key takeaways: Of 145,410 adults who began a GLP-1 drug, 76 developed thyroid cancer over a mean 3.9 years of follow-up
The protocol called for patients to receive daily subcutaneous injections for 28 days
DTB Methylcobalamin (Vitamin B12) - Intranasal Liposomal Delivery - Nasal Spray 100mcg - 30ml
BMC Nephrol 22(1):341
US$ 23.56
US$ 24.33
US$ 29.65
US$ 28.05
US$ 29.43
US$ 22.20
US$ 25.35
